Latest Insurance News

Korvest Ltd has reported a record financial year with revenue up 16.2%, driven by major infrastructure projects, and declared a special dividend alongside plans for a significant Kilburn site upgrade.

Korvest Ltd reported a strong FY25 with revenues up 16.2% and net profit after tax rising 19.1%, supported by major infrastructure projects and operational resilience. The company declared a fully franked final dividend plus a special dividend, while advancing plans to expand its Kilburn manufacturing site.

Gratifii Limited has posted a record $19.4 million in cash receipts for 4Q FY25, marking a 210% year-on-year increase and signaling strong momentum as it nears completion of its platform migration and expands its Member’s Mobile offering.

Lloyds Banking Group reported a robust first half in 2025, with net income up 6%, strong lending growth, and a 15% increase in its interim dividend. The bank reaffirmed its 2025 guidance and expressed confidence in meeting ambitious 2026 targets.

Yowie Group Limited has explained the delayed filing of director interest notices following a contested board change, committing to stronger governance measures to prevent future lapses.

One Click Group Limited has outpaced its entire July 2024 revenue within the first 18 days of July 2025, defying a broader decline in tax lodgements and showcasing strong customer loyalty.

Credit Clear Limited has outperformed its FY25 financial guidance with a 76% rise in underlying EBITDA and secured exclusive digital debt recovery contracts with leading insurers, setting a robust stage for FY26 growth.

Coast Entertainment Holdings reports a robust FY25 with double-digit growth in visitation and revenue, driven by new attractions and strong promotional campaigns. Despite weather disruptions and cautious international recovery, the company starts FY26 on a high note.

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.

Connexion Mobility reported steady revenue growth and a 7% increase in net profit before tax for Q4 FY25, driven by expanding SaaS subscriptions and strategic product enhancements.

TAL Dai-ichi Life Australia has obtained all necessary regulatory approvals, including from APRA, to finalize its minority investment in Challenger Limited, acquiring a 19.9% equity stake.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.